MarkI 68A Cesium-137 Gamma Irradiator
MarkI 68A 铯-137 伽马辐照器
基本信息
- 批准号:8053023
- 负责人:
- 金额:$ 37.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAgeAnimalsAntigen PresentationAntigen-Presenting CellsAutoimmune DiseasesB-Cell DevelopmentBiomedical ResearchBone MarrowCellsCellular biologyCesiumChagas DiseaseCommunicable DiseasesComplexDevelopmentEnvironmentFundingFunding ApplicantGoalsGrowthImmunologistInvestigationIsotopesLifeMaintenanceMusParasitesResearchResearch PersonnelT-Cell ActivationT-LymphocyteTransplantationTrypanosoma cruziUnited States National Institutes of HealthUniversitiesWhole-Body Irradiationbiological researchdesigninstrumentinstrumentationirradiationmeetingsvaccine development
项目摘要
DESCRIPTION (provided by applicant): Funds are requested for the purchase of a Mark I Cesium 137 gamma irradiator designed for whole body irradiation of mice, a capability that is lacking at the University of Georgia. Major research applications that require this instrument include 1) ablation of host bone marrow prior to transplantation for generating bone marrow chimeric mice, 2) irradiation of antigen presenting cells for use in studies of T cell activation and development, and 3) providing an environment for efficient growth and isolation of Trypanosoma cruzi parasites. The major users group comprises 10 NIH-funded researchers from four Departments at UGA. The only irradiator currently available to UGA investigators is a Gamma Cell 200 irradiator provided through the Center for Applied Isotope Studies and, due to its age and increasing unreliability, is in need of a replacement unit that can meet the needs of the growing number of immunologists at UGA. In addition, that instrument is not appropriate for irradiating live animals for immunological research. Acquisition of the proposed irradiator will provide new capabilities that will allow investigators to address complex immunological and cell biological research problems. Specific lines of investigation that will directly benefit from the purchase of the instrument include: T and B cell development and functions in infectious and autoimmune disease settings, antigen presentation and vaccine development, and the cell biology of T. cruzi, the causative agent of Chagas' Disease. The instrumentation will therefore facilitate the realization of research goals and maintenance of NIH support for biomedical research.
说明(由申请人提供):申请资金用于购买一台Mark I铯137伽马辐照器,该辐照器设计用于小鼠全身辐照,这是格鲁吉亚大学所缺乏的能力。需要该仪器的主要研究应用包括1)在移植之前消融宿主骨髓以产生骨髓嵌合小鼠,2)照射抗原呈递细胞以用于T细胞活化和发育的研究,以及3)提供用于有效生长和分离克氏锥虫寄生虫的环境。主要用户组包括10个NIH资助的研究人员从四个部门在UGA。唯一的辐照器目前可用于UGA调查是通过应用同位素研究中心提供的伽马细胞200辐照器,由于其年龄和日益增加的不可靠性,需要更换单元,以满足UGA越来越多的免疫学家的需求。此外,该仪器不适合用于辐照活体动物进行免疫学研究。获得拟议的辐照器将提供新的能力,使研究人员能够解决复杂的免疫学和细胞生物学研究问题。购买该仪器将直接受益的具体研究领域包括:T和B细胞的发育和在感染性和自身免疫性疾病中的功能,抗原呈递和疫苗开发,以及T细胞的细胞生物学。克氏锥虫病的病原体。因此,该仪器将有助于实现研究目标,并维持NIH对生物医学研究的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy T Watford其他文献
The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-γ-induced cell death
免疫相关 GTP 酶 Irgm1 通过防止干扰素-γ诱导的细胞死亡来促进活化 CD4+T 细胞群体的扩增
- DOI:
10.1038/ni.1653 - 发表时间:
2008-09-21 - 期刊:
- 影响因子:27.600
- 作者:
Carl G Feng;Lixin Zheng;Dragana Jankovic;André Báfica;Jennifer L Cannons;Wendy T Watford;Damien Chaussabel;Sara Hieny;Patricia Caspar;Pamela L Schwartzberg;Michael J Lenardo;Alan Sher - 通讯作者:
Alan Sher
Interleukin-22: a sheep in wolf's clothing
白细胞介素-22:披着羊皮的狼
- DOI:
10.1038/nm0308-247 - 发表时间:
2008-03-01 - 期刊:
- 影响因子:50.000
- 作者:
Arian Laurence;John J O'Shea;Wendy T Watford - 通讯作者:
Wendy T Watford
Wendy T Watford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy T Watford', 18)}}的其他基金
Tpl2 regulation of pDC function and SLE pathogenesis
Tpl2 对 pDC 功能和 SLE 发病机制的调节
- 批准号:
10242226 - 财政年份:2020
- 资助金额:
$ 37.26万 - 项目类别:
Tpl2 regulation of pDC function and SLE pathogenesis
Tpl2 对 pDC 功能和 SLE 发病机制的调节
- 批准号:
10064466 - 财政年份:2020
- 资助金额:
$ 37.26万 - 项目类别:
Regulation of mucosal immunity to respiratory viruses by Tpl2
Tpl2对呼吸道病毒粘膜免疫的调节
- 批准号:
9809582 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
Regulation of mucosal immunity to respiratory viruses by Tpl2
Tpl2对呼吸道病毒粘膜免疫的调节
- 批准号:
9926820 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
MAP3K8 介导的适应性免疫反应和自身免疫的调节
- 批准号:
8439506 - 财政年份:2012
- 资助金额:
$ 37.26万 - 项目类别:
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
MAP3K8 介导的适应性免疫反应和自身免疫的调节
- 批准号:
8535939 - 财政年份:2012
- 资助金额:
$ 37.26万 - 项目类别:
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
MAP3K8 介导的适应性免疫反应和自身免疫的调节
- 批准号:
9181374 - 财政年份:2012
- 资助金额:
$ 37.26万 - 项目类别:
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
MAP3K8 介导的适应性免疫反应和自身免疫的调节
- 批准号:
8586250 - 财政年份:2012
- 资助金额:
$ 37.26万 - 项目类别:
Tp12-dependent IFN-g production: contribution to host defense and autoimmunity
Tp12 依赖性 IFN-g 产生:对宿主防御和自身免疫的贡献
- 批准号:
7901083 - 财政年份:2009
- 资助金额:
$ 37.26万 - 项目类别:
Tp12-dependent IFN-g production: contribution to host defense and autoimmunity
Tp12 依赖性 IFN-g 产生:对宿主防御和自身免疫的贡献
- 批准号:
8121441 - 财政年份:2009
- 资助金额:
$ 37.26万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Research Grant